The Rundown cover image

AMD Earnings Fail to Impress, Novo Nordisk Cuts Outlook Amid Obesity Drug Pricing Pressure

The Rundown

00:00

Novo Nordisk Lowers Outlook Amid Pricing Pressure

Zaid details Novo Nordisk's lowered guidance, GLP-1 pricing talks with the U.S., WeGovie sales, and Metsera bidding war.

Play episode from 03:38
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app